Natural MedTech is an Australian startup aiming to revolutionize the biotechnology and pharmaceutical industries by manufacturing and developing psychedelic medicines to unlock neurologic potential. Established in 2019, the company prides itself on being Australia's leading pure-play psychedelic business, boasting differentiated intellectual property and an experienced team. Their self-funding growth profile is a testament to their commitment and potential for future success.
The company recently secured a significant Seed Round investment on 01 January 2021, with Tabula Rasa Ventures backing their vision. This injection of capital will undoubtedly fuel their efforts in pioneering breakthroughs in psychedelic medicines and further establishing their presence in the industry.